Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
JTO Clin Res Rep
; 3(6): 100330, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35719865
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
JTO Clin Res Rep
Year:
2022
Document type:
Article
Country of publication: